Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines. The company was founded in 1981 and is based in Shanghai, China.
Metrics to compare | 603718 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603718PeersSector | |
---|---|---|---|---|
P/E Ratio | 25.2x | 29.9x | −0.5x | |
PEG Ratio | 0.12 | −0.40 | 0.00 | |
Price/Book | 3.0x | 2.1x | 2.6x | |
Price / LTM Sales | 17.8x | 3.7x | 3.0x | |
Upside (Analyst Target) | - | 11.3% | 52.7% | |
Fair Value Upside | Unlock | 0.7% | 7.6% | Unlock |